{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T19:41:11Z","timestamp":1707939671905},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1007\/s11938-999-0060-z","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T15:11:50Z","timestamp":1180883510000},"page":"205-213","source":"Crossref","is-referenced-by-count":3,"title":["Preventing NSAID toxicity to the upper gastrointestinal tract"],"prefix":"10.1007","volume":"2","author":[{"given":"James M.","family":"Scheiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"60_CR1","first-page":"25","volume":"73","author":"Stat Bull Metrop Insur Co.","year":"1992","unstructured":"Stat Bull Metrop Insur Co. Antiarthritis medication usage, United States, 1991. 1992, 73:25\u201334.","journal-title":"Antiarthritis medication usage, United States, 1991"},{"key":"60_CR2","first-page":"16","volume":"25","author":"G Singh","year":"1998","unstructured":"Singh G, Ramey DR: NSAID-induced gastrointestinal complications: the ARAMIS perspective-1997. J Rheumatol 1998, 25:16.","journal-title":"J Rheumatol"},{"key":"60_CR3","first-page":"G0555","volume":"114","author":"JL Goldstein","year":"1998","unstructured":"Goldstein JL: Public misunderstanding of nonsteroidal antiinflammatory drug (NSAID)-mediated gastrointestinal complications toxicity: a serious potential health threat. Gastroenterology 1998, 114:G0555.","journal-title":"Gastroenterology"},{"key":"60_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0889-8553(05)70247-8","volume":"25","author":"JM Scheiman","year":"1996","unstructured":"Scheiman JM: NSAIDs, cytoprotection, and gastrointestinal injury. Gastroenterol Clin North Am 1996, 25:279\u2013298.","journal-title":"Gastroenterol Clin North Am"},{"key":"60_CR5","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.91.6.2046","volume":"91","author":"JR Vane","year":"1994","unstructured":"Vane JR, Mitchell JA, Appelton I, et al.: Inducible isoforms of cyclooxygenase and nitric acid synthase in inflammation. Proc Natl Acad Sci U S A 1994, 91:2046\u20132050.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"60_CR6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9343(98)00091-6","volume":"104","author":"B Cryer","year":"1998","unstructured":"Cryer B, Feldman M: Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal antiinflammatory drugs. Am J Med 1998, 104:413\u2013421. This paper highlights the difficulties in characterizing NSAIDs selectively for COX isoenzymes.","journal-title":"Am J Med"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0049-0172(90)90025-B","volume":"20","author":"JM Scheiman","year":"1990","unstructured":"Scheiman JM, Elta GH: Gastroduodenal mucosal damage with salsalate versus aspirin: results of experimental models and endoscopic studies in humans. Semin Arthritis Rheum 1990, 20:121\u2013127.","journal-title":"Semin Arthritis Rheum"},{"key":"60_CR8","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1001\/archinte.1993.00410220073008","volume":"153","author":"SH Roth","year":"1993","unstructured":"Roth SH, Tindall EA, Jain AD, et al.: A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal mucosa. Arch Intern Med 1993, 153:2565\u20132571.","journal-title":"Arch Intern Med"},{"key":"60_CR9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0016-5107(95)70045-5","volume":"42","author":"L Laine","year":"1995","unstructured":"Laine L, Sloane R, Ferretti M, Cominelli F: A randomized, double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production. Gastrointest Endosc 1995, 42:428\u2013433.","journal-title":"Gastrointest Endosc"},{"key":"60_CR10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gut.37.4.509","volume":"37","author":"J Slattery","year":"1995","unstructured":"Slattery J, Warlow CP, Shorrock CJ, Langman MJS: Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin-analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995, 37:509\u2013511.","journal-title":"Gut"},{"key":"60_CR11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00004836-199006000-00005","volume":"12","author":"JH Kurata","year":"1990","unstructured":"Kurata JH, Abbey DE: The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol 1990, 12:260\u2013266.","journal-title":"J Clin Gastroenterol"},{"key":"60_CR12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.310.6983.827","volume":"310","author":"J Weil","year":"1995","unstructured":"Weil J, Colin-Jones D, Langman M, et al.: Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995, 310:827\u2013830.","journal-title":"BMJ"},{"key":"60_CR13","doi-asserted-by":"crossref","first-page":"A77","DOI":"10.1016\/0016-5085(95)22971-X","volume":"108","author":"B Cryer","year":"1995","unstructured":"Cryer B, Luk G, Feldman M: Effects of very low doses of aspirin (ASA) on gastric duodenal and rectal prostaglandins (PG2) and mucosal injury. Gastroenterology 1995, 108:A77.","journal-title":"Gastroenterology"},{"key":"60_CR14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","volume":"123","author":"F Silverstein","year":"1995","unstructured":"Silverstein F, Graham D, Senior J, et al.: Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995, 123:241\u2013249.","journal-title":"Ann Intern Med"},{"key":"60_CR15","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/bmj.312.7046.1563","volume":"312","author":"D Henry","year":"1996","unstructured":"Henry D, Lim L, Garcia Rodriguez L, et al.: Variability in risk of gastrointestinal complications with individual NSAIDs: results of a collaborative meta-analysis. BMJ 1996, 312:1563\u20131566. This provides an important synthesis of data on the relative ulcerogenicity of various NSAIDs.","journal-title":"BMJ"},{"key":"60_CR16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/gut.28.5.527","volume":"28","author":"CP Armstrong","year":"1987","unstructured":"Armstrong CP, Blower AL: Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987, 28:527\u2013532.","journal-title":"Gut"},{"key":"60_CR17","doi-asserted-by":"crossref","first-page":"A144","DOI":"10.1053\/gast.1997.v112.pm9041232","volume":"112","author":"CJ Hawkey","year":"1997","unstructured":"Hawkey CJ, Langstrom G, Naesdal J, Yeomans N: Significance of symptoms during healing and maintenance of NSAID-associated gastroduodenal lesions with omeprazole, misoprostol, and ranitidine. Gastroenterology 1997, 112:A144.","journal-title":"Gastroenterology"},{"key":"60_CR18","first-page":"1516","volume":"88","author":"SH Roth","year":"1993","unstructured":"Roth SH: Efficacy of antacid therapy for NSAIDinduced symptomatic gastropathy. Am J Gastroenterol 1993, 88:1516.","journal-title":"Am J Gastroenterol"},{"issue":"suppl 2","key":"60_CR19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2036.1988.tb00767.x","volume":"2","author":"JW Bijlsma","year":"1988","unstructured":"Bijlsma JW: Treatment of endoscopy-negative NSAIDinduced upper gastrointestinal symptoms with cimetidine: an international multicentre collaborative study. Aliment Pharmacol Ther 1988, 2(suppl 2):75\u201384.","journal-title":"Aliment Pharmacol Ther"},{"key":"60_CR20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/00365529609010347","volume":"31","author":"P Ekstrom","year":"1996","unstructured":"Ekstrom P, Carling L, Wetterhus S, et al.: Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. Scand J Gastroenterol 1996, 31:753\u2013758.","journal-title":"Scand J Gastroenterol"},{"key":"60_CR21","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(88)92892-9","volume":"2","author":"D Graham","year":"1988","unstructured":"Graham D, Agrawal N, Roth S: Prevention of NSAIDinduced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1988, 2:1277\u20131280.","journal-title":"Lancet"},{"key":"60_CR22","first-page":"223","volume":"91","author":"JB Raskin","year":"1996","unstructured":"Raskin JB, White R, Jaszewski R, et al.: Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double blind, multicenter study. Am J Gastroenterol 1996, 91:223\u2013227.","journal-title":"Am J Gastroenterol"},{"key":"60_CR23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-123-5-199509010-00004","volume":"123","author":"JB Raskin","year":"1995","unstructured":"Raskin JB, White RH, Jackson JE: Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens. Ann Intern Med 1995, 123:344\u2013350.","journal-title":"Ann Intern Med"},{"key":"60_CR24","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM199605303342204","volume":"334","author":"AS Taha","year":"1996","unstructured":"Taha AS, Hudson N, Hawkey CJ, et al.: Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs. N Engl J Med 1996, 334:1435\u20131439.","journal-title":"N Engl J Med"},{"key":"60_CR25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2036.1998.00288.x","volume":"12","author":"D Cullen","year":"1998","unstructured":"Cullen D, Bardhan KD, Eisner M, et al.: Primary gastroduodenal prophylaxis with omeprazole for NSAID users. Aliment Pharmacol Ther 1998, 12:135\u2013140.","journal-title":"Aliment Pharmacol Ther"},{"key":"60_CR26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","volume":"338","author":"ND Yeomans","year":"1998","unstructured":"Yeomans ND, Zsolt T, Juhasz L, et al.: A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998, 338:719\u2013726.","journal-title":"N Engl J Med"},{"key":"60_CR27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","volume":"338","author":"CJ Hawkey","year":"1998","unstructured":"Hawkey CJ, Karrasch JA, Szczepanski L, et al.: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998, 338:727\u2013734. This paper supports the use of proton-pump inhibitors as an alternative to misoprostol for NSAID prophylaxis.","journal-title":"N Engl J Med"},{"key":"60_CR28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","volume":"384","author":"RG Kurumbail","year":"1996","unstructured":"Kurumbail RG, Stevens AM, Gierse JK, et al.: Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996, 384:644\u2013648.","journal-title":"Nature"},{"key":"60_CR29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","volume":"353","author":"CJ Hawkey","year":"1999","unstructured":"Hawkey CJ: COX-2 inhibitors. Lancet 1999, 353:307\u2013314. This is a timely, comprehensive review.","journal-title":"Lancet"},{"key":"60_CR30","unstructured":"Hawkey C, Laine L, Simon T, et al.: A comparison of the effect of rofecoxib (a COX-2 specific inhibitor), ibuprofen, or placebo on the gastroduodenal mucosa of osteoarthritics. In press."},{"key":"60_CR31","first-page":"34","volume":"124","author":"JM Scheiman","year":"1997","unstructured":"Scheiman JM: Commentary on \u201cMeta analysis: Misoprostol reduced NSAID-induced gastrointestinal injury.\u201d ACP J Club 1997, 124:34.","journal-title":"ACP J Club"},{"key":"60_CR32","first-page":"204","volume":"28","author":"LS Simon","year":"1996","unstructured":"Simon LS, Hatoum HT, Bittman RM, et al.: Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA Trial. Fam Med 1996, 28:204\u2013210.","journal-title":"Fam Med"},{"key":"60_CR33","unstructured":"Quang-Hiang J, Hunt R: Gastrointestinal complications associated with nabumetone. Am J Med 1999, In press."},{"key":"60_CR34","doi-asserted-by":"crossref","first-page":"A120","DOI":"10.1016\/S0016-5085(98)80489-7","volume":"114","author":"AM Fendrick","year":"1998","unstructured":"Fendrick AM, Bandekar R, Chernew ME, Scheiman JM: Impact of NSAID choice and patient symptoms on the cost-effectiveness of strategies to prevent NSAID gastropathy. Gastroenterology 1998, 114:A120.","journal-title":"Gastroenterology"},{"key":"60_CR35","doi-asserted-by":"crossref","unstructured":"Schoenfeld P: Gastrointestinal safety profile of meloxicam: a meta-analysis and systematic review of randomized controlled trials. Am J Med 1999, In press.","DOI":"10.1016\/S0002-9343(99)00367-8"},{"key":"60_CR36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(95)90341-0","volume":"109","author":"SN Elliott","year":"1995","unstructured":"Elliott SN, McKnight W, Cirino G, Wallace JL: A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 1995, 109:524\u2013533.","journal-title":"Gastroenterology"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-999-0060-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-999-0060-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-999-0060-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T19:13:41Z","timestamp":1707938021000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-999-0060-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s11938-999-0060-z","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}